title: How should we treat "difficult" multidrug-resistant tuberculosis?
authors.affiliation: Tuberculosis and Chest Unit, Grantham Hospital, Hong Kong, People's Republic of China; Tuberculosis and Chest Unit, Grantham Hospital, Hong Kong, People's Republic of China. Electronic address: yewww@ha.org.hk.
authors.forename: Wing Wai
authors.initials: WW
authors.lastname: Yew
authors.affiliation: Tuberculosis and Chest Service, Department of Health, Hong Kong, People's Republic of China; Tuberculosis and Chest Unit, Grantham Hospital, Hong Kong, People's Republic of China.
authors.forename: Chi Chiu
authors.initials: CC
authors.lastname: Leung
mesh_terms: D000081:Acetamides / Q000008:administration & dosage*; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069349:Linezolid; D008297:Male; D020714:Maximum Tolerated Dose; D023303:Oxazolidinones / Q000008:administration & dosage*; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid